| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.25▲ | 3.30▲ | 3.32▲ | 3.11▲ | 3.41▼ |
| MA10 | 3.28▲ | 3.20▲ | 3.13▲ | 3.17▲ | 3.43▼ |
| MA20 | 3.15▲ | 3.05▲ | 3.08▲ | 3.40▼ | 3.46▼ |
| MA50 | 3.01▲ | 3.11▲ | 3.18▲ | 3.45▼ | 7.32▼ |
| MA100 | 3.12▲ | 3.36▼ | 3.50▼ | 3.45▼ | N/A |
| MA200 | 3.42▼ | 3.66▼ | 3.52▼ | 4.67▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.049▲ | 0.055▲ | -0.023▼ | N/A |
| RSI | 65.137▲ | 61.533▲ | 59.080▲ | 47.979▼ | N/A |
| STOCH | 48.788 | 88.635▲ | 93.503▲ | 40.122 | 48.213 |
| WILL %R | -16.667▲ | -8.000▲ | -6.667▲ | -40.336 | -56.707 |
| CCI | 90.265 | 81.693 | 81.934 | 26.127 | -111.606▼ |
| MA | $APTX Price Crossed Above MA(13) | Set Alert |
|
Tuesday, October 15, 2019 05:54 AM
EVANSTON, Ill., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/19 | 3.23 | 3.37 | 3.18 | 3.32 | 33,500 |
| 15/10/19 | 2.83 | 3.39 | 2.83 | 3.21 | 191,900 |
| 14/10/19 | 3.07 | 3.11 | 2.61 | 2.84 | 398,100 |
| 11/10/19 | 3.17 | 3.22 | 3.01 | 3.09 | 171,400 |
| 10/10/19 | 3.10 | 3.16 | 2.97 | 3.11 | 72,600 |
| 09/10/19 | 3.11 | 3.23 | 3.01 | 3.08 | 71,600 |
| 08/10/19 | 3.24 | 3.32 | 3.05 | 3.20 | 139,700 |
| 07/10/19 | 3.26 | 3.35 | 3.02 | 3.24 | 266,300 |
| 04/10/19 | 3.29 | 3.37 | 3.11 | 3.28 | 29,814 |
| 03/10/19 | 3.29 | 3.455 | 3.20 | 3.29 | 45,675 |
|
|
||||
|
|
||||
|
|